Advances in the development of HIV integrase strand transfer inhibitors

被引：17
作者：
Wang, Yue [1 ]
Gu, Shuang-Xi [2 ,3 ]
He, Qiuqin [1 ]
Fan, Renhua [1 ]
机构：
[1] Fudan Univ, Dept Chem, 2005 Songhu Rd, Shanghai 200438, Peoples R China
[2] Wuhan Inst Technol, Sch Chem Engn & Pharm, Key Lab Green Chem Proc, Minist Educ, Wuhan 430205, Peoples R China
[3] Wuhan Inst Technol, Hubei Key Lab Novel Reactor & Green Chem Technol, Wuhan 430205, Peoples R China
来源：
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2021年 / 225卷
基金：
中国国家自然科学基金;
关键词：
HIV-1; integrase; Strand transfer inhibitors; Metal chelating; Resistance; ZINC-BINDING DOMAIN; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; STRUCTURAL BASIS; RALTEGRAVIR; RESISTANT; DOLUTEGRAVIR; ORGANIZATION; ELVITEGRAVIR; REPLICATION;
D O I：
10.1016/j.ejmech.2021.113787
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
HIV-1 integrase (IN) is a key enzyme in viral replication that catalyzes the covalent integration of viral cDNA into the host genome. Currently, five HIV-1 IN strand transfer inhibitors (INSTIs) are approved for clinical use. These drugs represent an important addition to the armamentarium for antiretroviral therapy. This review briefly illustrates the development history of INSTIs. The characteristics of the currently approved INSTIs, as well as their future perspectives, are critically discussed. (C) 2021 Elsevier Masson SAS. All rights reserved.
引用
收藏
页数：10
相关论文
共 50 条
  • [21] Impact of combinations of clinically observed HIV integrase mutations on phenotypic resistance to integrase strand transfer inhibitors (INSTIs): a molecular study
    Cheung, Peter K.
    Shahid, Aniqa
    Dong, Winnie
    Lepik, Katherine J.
    Montaner, Julio S. G.
    Brockman, Mark A.
    Brumme, Zabrina L.
    Brumme, Chanson J.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (04) : 979 - 988
  • [22] Primary resistance to integrase strand-transfer inhibitors in Europe
    Casadella, M.
    van Ham, P. M.
    Noguera-Julian, M.
    van Kessel, A.
    Pou, C.
    Hofstra, L. M.
    Santos, J. R.
    Garcia, F.
    Struck, D.
    Alexiev, I.
    Kran, A. M. Bakken
    Hoepelman, A. I.
    Kostrikis, L. G.
    Somogyi, S.
    Liitsola, K.
    Linka, M.
    Nielsen, C.
    Otelea, D.
    Paraskevis, D.
    Poljak, M.
    Puchhammer-Stoeckl, E.
    Stanekova, D.
    Stanojevic, M.
    Van Laethem, K.
    Lepej, S. Zidovec
    Clotet, B.
    Boucher, C. A. B.
    Paredes, R.
    Wensing, A. M. J.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (10) : 2885 - 2888
  • [23] Structural Biology of HIV Integrase Strand Transfer Inhibitors
    Jozwik, Ilona K.
    Passos, Dario O.
    Lyumkis, Dmitry
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2020, 41 (09) : 611 - 626
  • [24] The design of 8-hydroxyquinoline tetracyclic lactams as HIV-1 integrase strand transfer inhibitors
    Velthuisen, Emile J.
    Johns, Brian A.
    Temelkoff, David P.
    Brown, Kevin W.
    Danehower, Susan C.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 117 : 99 - 112
  • [25] Structure-Guided Optimization of HIV Integrase Strand Transfer Inhibitors
    Zhao, Xue Zhi
    Smith, Steven J.
    Maskell, Daniel P.
    Metifiot, Mathieu
    Pye, Valerie E.
    Fesen, Katherine
    Marchand, Christophe
    Pommier, Yves
    Cherepanov, Peter
    Hughes, Stephen H.
    Burke, Terrence R., Jr.
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (17) : 7315 - 7332
  • [26] Adverse drug reactions to integrase strand transfer inhibitors
    Lepik, Katherine J.
    Yip, Benita
    Ulloa, Ana C.
    Wang, Lu
    Toy, Junine
    Akagi, Linda
    Lima, Viviane Dias
    Guillemi, Silvia
    Montaner, Julio S. G.
    Barrios, Rolando
    AIDS, 2018, 32 (07) : 903 - 912
  • [27] HIV-1 integrase strand transfer inhibitors: a review of current drugs, recent advances and drug resistance
    Mbhele, Nokuzola
    Chimukangara, Benjamin
    Gordon, Michelle
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2021, 57 (05)
  • [28] Different Pathways Conferring Integrase Strand-Transfer Inhibitors Resistance
    Richetta, Clemence
    Tu, Nhat Quang
    Delelis, Olivier
    VIRUSES-BASEL, 2022, 14 (12):
  • [29] Clinical Outcomes of Integrase Strand Transfer Inhibitors Containing Antiretroviral Therapy in HIV-2: A Narrative Review
    Boschloo, Wendy J.
    van Welzen, Berend J.
    INFECTIOUS DISEASES AND THERAPY, 2024, 13 (06) : 1161 - 1175
  • [30] Mutations Located outside the Integrase Gene Can Confer Resistance to HIV-1 Integrase Strand Transfer Inhibitors
    Malet, Isabelle
    Subra, Frederic
    Charpentier, Charlotte
    Collin, Gilles
    Descamps, Diane
    Calvez, Vincent
    Marcelin, Anne-Genevieve
    Delelis, Olivier
    MBIO, 2017, 8 (05):
12345